Kiora Pharmaceuticals

EyeGate Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing drugs for the treatment of eye diseases using its non-invasive iontophoresis drug delivery system. It is developing a proprietary drug platform utilizing its unique, non-invasive iontophoresis drug delivery system, called EyeGate, to treat ocular conditions. On November 8, 2021, Eyegate Pharmaceuticals, Inc. changed its name to Kiora Pharmaceuticals, Inc.